Statistical Analysis The one-way ANOVA analysis and unpaired Student’s t-Test was performed using the GrapPad Prism 6.0 program. Acknowledgments We thank Dr. Isaiah J. Fidler for H-2kb-ts58 mice and Dr. Robert R. Langley for technical support for isolation and culture of mouse epithelial References 1. Conlon I, Raff M (1999) Size control in animal development. Cell 96: 235–244. 2. Conlon I, Raff M (2004) Control and maintenance of mammalian cell size: response. BMC Cell Biol 5: 36. 3. Conlon IJ, Dunn GA, Mudge AW, Raff MC (2001) Extracellular control of cell size. Nat Cell Biol 3: 918–921. 4. Cunha GR, Donjacour AA, Cooke PS, Mee S, Bigsby RM, et al. (1987) The endocrinology and developmental biology of the prostate. Endocr Rev 8: 338– 362. 5. Meeks JJ, Schaeffer EM (2011) Genetic regulation of prostate development. J Androl 32: 210–217. 6. Cunha GR (1975) Age-dependent loss of sensitivity of female urogenital sinus to androgenic conditions as a function of the epithelia-stromal interaction in mice. Endocrinology 97: 665–673. 7. Cooke PS, Young P, Cunha GR (1991) Androgen receptor expression in developing male reproductive organs. Endocrinology 128: 2867–873. 8. Swerdloff RS, Wang C (2004) Androgens and the ageing male. Best Pract Res Clin Endocrinol Metab 18: 349–62. 9. Feldman HA, Longcope C, Derby CA, Johannes CB, Araujo AB, et al. (2002) Age trends in the level of serum testosterone and other hormones in middle-aged men: longitudinal results from the Massachusetts male aging study. J Clin Endocrinol Metab 87: 589–598. 10. Berry SJ, Coffey DS, Walsh PC, Ewing LL (1984) The development of human benign prostatic hyperplasia with age. J Urol 132: 474–479. 11. Glynn RJ, Campion EW, Bouchard GR, Silbert JE (1985) The development of benign prostatic hyperplasia among volunteers in the Normative Aging Study. Am J Epidemiol 121: 78–90. 12. Joshua AM, Evans A, Van der Kwast T, Zielenska M, Meeker AK, et al. (2008) Prostatic preneoplasia and beyond. Biochim Biophys Acta 1785: 156–181. 13. Konishi N, Shimada K, Ishida E, Nakamura M (2005) Molecular pathology of prostate cancer. Pathol Int 55: 531–539. 14. Montironi R, Mazzucchelli R, Lopez-Beltran A, Cheng L, Scarpelli M (2007) Mechanisms of disease: high-grade prostatic intraepithelial neoplasia and other proposed preneoplastic lesions in the prostate. Nat Clin Pract Urol 4: 321–332. 15. Bostwick DG, Brawer MK (1987) Prostatic intra-epithelial neoplasia and early invasion in prostate cancer. Cancer 59: 788–794. 16. Hosohata K, Li P, Hosohata Y, Qin J, Roeder RG, et al. (2003) Purification and identification of a novel complex which is involved in androgen receptor- dependent transcription. Mol Cell Biol 23: 7019–7029. 17. Gao S, Wu H, Wang F, Wang Z (2010) Altered differentiation and proliferation of prostate epithelium in mice lacking the androgen receptor cofactor p44/ WDR77. Endocrinology 151: 3941–3953. 18. Zhou L, Wu H, Lee P, Wang Z (2006) Roles of the androgen receptor cofactor p44 in the growth of prostate epithelial cells. J Mol Endocrinol 37: 283–300. 19. Peng Y, Chen F, Melamed J, Chiriboga L, Wei J, et al. (2008) Distinct nuclear and cytoplasmic functions of androgen receptor cofactor p44 and association with androgen-independent prostate cancer. Proc Natl Acad Sci U S A 105: 5236–5241. 20. Friesen WJ, Wyce A, Paushkin S, Abel L, Rappsilber J, et al. (2002) A novel WD repeat protein component of the methylosome binds Sm proteins. J Biol Chem.: 8243–8247. 21. Meister G, Eggert C, Buhler D, Brahms H, Kambach C, et al. (2001) Methylation of Sm proteins by a complex containing PRMT5 and the putative U snRNP assembly factor pICln. Curr Biol 11: 1990–1994. p44 Functions in Prostate Epithelial Cells cells. We also thank Zachary S. Bohannan and Kathryn Carnes for critical editorial review of the manuscript. Author Contributions Conceived and designed the experiments: ZW. Performed the experiments: SG. Analyzed the data: ZW. Wrote the paper: ZW. 22. Friesen WJ, Paushkin S, Wyce A, Massenet S, Pesiridis GS, et al. (2001) The methylosome, a 20S complex containing JBP1 and pICln, produces dimethy- larginine-modified Sm proteins. Mol Cell Biol 21: 8289–8300. 23. Meister G, Fischer U (2002) Assisted RNP assembly: SMN and PRMT5 complexes cooperate in the formation of spliceosomal UsnRNPs. Embo J 21: 5853–5863. 24. Shen EC, Henry MF, Weiss VH, Valentini SR, Silver PA, et al. (1998) Arginine methylation facilitates the nuclear export of hnRNP proteins. Genes Dev 12: 679–691. 25. Gu Z, Zhou L, Gao S, Wang Z (2012) Nuclear Transport Signals Control Cellular Localization and Function of Androgen Receptor Cofactor p44/ WDR77. PLoS One 6: e22395. 26. Gu Z, Zhang F, Wang ZQ, Ma W, Davis RE, et al. (2012) The p44/wdr77- dependent cellular proliferation process during lung development is reactivated in lung cancer. Oncogene. 27. Xue Y, Smedts F, Debruyne FM, de la Rosette JJ, Schalken JA (1998) Identification of intermediate cell types by keratin expression in the developing human prostate. Prostate 34: 292–301. 28. Hayward SW, Baskin LS, Haughney PC, Cunha AR, Foster BA, et al. (1996) Epithelial development in the rat ventral prostate, anterior prostate and seminal vesicle. Acta Anat (Basel) 155: 81–93. 29. Timms BG, Mohs TJ, Didio LJ (1994) Ductal budding and branching patterns in the developing prostate. J Urol 151: 1427–1432. 30. Kellokumpu-Lehtinen P (1985) Development of sexual dimorphism in human urogenital sinus complex. Biol Neonate 48: 157–167. 31. Fujimoto N, Akimoto Y, Suzuki T, Kitamura S, Ohta S (2006) Identification of prostatic-secreted proteins in mice by mass spectrometric analysis and evaluation of lobe-specific and androgen-dependent mRNA expression. J Endocrinol 190: 793–803. 32. Jat PS, Noble MD, Ataliotis P, Tanaka Y, Yannoutsos N, et al. (1991) Direct derivation of conditionally immortal cell lines from an H-2Kb-tsA58 transgenic mouse. Proc Natl Acad Sci U S A 88: 5096–5100. 33. Langley RR, Ramirez KM, Tsan RZ, Van Arsdall M, Nilsson MB, et al. (2003) Tissue-specific microvascular endothelial cell lines from H-2K(b)-tsA58 mice for studies of angiogenesis and metastasis. Cancer Res 63: 2971–2976. 34. Shackney SE, Shankey TV (1999) Cell cycle models for molecular biology and molecular oncology: exploring new dimensions. Cytometry 35: 97–116. 35. Halevy O, Novitch BG, Spicer DB, Skapek SX, Rhee J, et al. (1995) Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD. Science 267: 1018–1021. 36. Sherr CJ, Roberts JM (1995) Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev 9: 1149–1163. 37. Andres V, Walsh K (1996) Myogenin expression, cell cycle withdrawal, and phenotypic differentiation are temporally separable events that precede cell fusion upon myogenesis. J Cell Biol 132: 657–666. 38. Sherr CJ, McCormick F (2002) The RB and p53 pathways in cancer. Cancer Cell 2: 103–112. 39. Sherr CJ (1994) G1 phase progression: cycling on cue. Cell 79: 551–555. 40. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real- time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402–408. PLOS ONE | www.plosone.org 14 November 2012 | Volume 7 | Issue 11 | e49173